Nanobiotix S.A. American Depositary Shares (NBTX) Technical Analysis
$25.75
Market is closed - opens 7 PM, 05 Oct 2026
Insights
- Nanobiotix S.A. (ADR) is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Nanobiotix S.A. (ADR) stock suggests that it is a good time to buy
- Based on analysis of the Moving Averages technical indicator, Nanobiotix S.A. (ADR) stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for Nanobiotix S.A. (ADR) stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 25.05 | Buy |
Stochastic | 4.42, 4.05 | Buy |
Ultimate Oscillator | 28.76 | Buy |
Stochastic Relative Strength Index | 0.0, 0.91 | Neutral |
Moving Average Convergence Divergence | -2.72, -1.95 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 32.06 | Sell |
20 | 34.16 | Sell |
50 | 37.83 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 31.22 | Sell |
20 | 33.63 | Sell |
50 | 36.39 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 31.29 | Sell |
20 | 33.6 | Sell |
50 | 37.99 | Sell |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 28.32 | Sell |
20 | 30.22 | Sell |
50 | 34.3 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 27.36 | Sell |
20 | 28.46 | Sell |
50 | 32.11 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 32.83 |
Resistance L2 | 31.59 |
Resistance L1 | 29.75 |
Pivot Point | 28.51 |
Support L1 | 26.67 |
Support L2 | 25.43 |
Support L3 | 23.59 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.